7/30/2023 0 Comments Xlag 3.0Interestingly, the expression level of SSTR2 was significantly higher in the control somatotropinomas (average IRS 7.9) compared with the AIPmut (average IRS 2.3) adenomas ( P=0.0026). The difference between AIPmut and controls was statistically significant for SSTR1 ( P=0.039) but not for SSTR5 ( P=0.239). SSTR1 and SSTR5 were present at higher levels in the controls vs AIPmut cases. SSTR3 was the most highly expressed receptor in both acromegaly controls (average IRS 9.8) and in AIPmut (average IRS 9.5) somatotropinomas. In AIPmut cases, one was negative for SSTR2, two for SSTR5 and three for SSTR1. Staining was assessed as negative for IRS 0≡, weakly positive for IRS 2≣, moderately positive for IRS 4≨, and strongly positive for IRS >8. ![]() Immunostains were evaluated semi-quantitatively and an immunoreactive score (IRS) was recorded for each section. We studied six XLAG and seven AIPmut patients, none of which had hormonal control on chronic SSA therapy, and ten mutation-negative patients (controls). ![]() ![]() We studied whether SSA resistance in these conditions was related to somatostatin receptor (SSTR) levels in tumour tissues. Two genetic syndromes are associated with relative SSA resistance: acromegaly due to AIP mutations (AIPmut) and the newly described X-linked acrogigantism (X-LAG) syndrome due to chromosome Xq26.3 microduplications. ![]() Poor hormonal and tumour responses to somatostatin analogues (SSA) in acromegaly can occur although the aetiology is often unclear.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |